Literature DB >> 18092233

HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways.

Veela B Mehta1, Gail E Besner.   

Abstract

OBJECTIVE: Heparin-binding EGF-like growth factor (HB-EGF) belongs to the epidermal growth factor (EGF) superfamily of ligands. It has been implicated as a regulator of angiogenesis. However, the mechanisms by which HB-EGF promotes angiogenesis are unknown. The goal of the present study was to define the pathways by which HB-EGF stimulates angiogenesis in endothelial cells.
METHODS: To characterize the angiogenic activity of HB-EGF, we treated human umbilical vein endothelial cells (HUVEC) with HB-EGF and analyzed the effects on cell proliferation, migration and tube formation. Side-by-side assays with EGF were used for comparison.
RESULTS: Both HB-EGF and EGF stimulated HUVEC migration in scratch assays and promoted vascular tube formation in 2D-angiogenesis assays, without inducing cell proliferation. HB-EGF- and EGF-induced HUVEC migration and capillary tube formation were dependent upon activation of PI3K, MAPK and eNOS. Importantly, HB-EGF-and EGF-induced tube formation was comparable to, but were independent of tube formation induced by VEGF.
CONCLUSIONS: We have demonstrated that HB-EGF and EGF induce angiogenesis via activation of PI3K, MAPK and eNOS in a VEGF-independent fashion. Thus, the role played by HB-EGF in stimulating physiologic processes such as wound healing in vivo may be dependent, in part, on its ability to promote angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092233     DOI: 10.1080/08977190701773070

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  54 in total

1.  Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.

Authors:  Gisela Weskamp; Karen Mendelson; Steve Swendeman; Sylvain Le Gall; Yan Ma; Stephen Lyman; Akinari Hinoki; Satoru Eguchi; Victor Guaiquil; Keisuke Horiuchi; Carl P Blobel
Journal:  Circ Res       Date:  2010-01-28       Impact factor: 17.367

2.  Heparin-binding EGF-like growth factor protects pericytes from injury.

Authors:  Xiaoyi Yu; Andrei Radulescu; Chun-Liang Chen; Iyore O James; Gail E Besner
Journal:  J Surg Res       Date:  2010-09-17       Impact factor: 2.192

3.  Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.

Authors:  Zhenyuan Li; Hao Yan; Jiangzi Yuan; Liou Cao; Aiwu Lin; Huili Dai; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  Clin Exp Nephrol       Date:  2017-07-14       Impact factor: 2.801

4.  Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection.

Authors:  Mark E McMellen; Derek Wakeman; Christopher R Erwin; Jun Guo; Brad W Warner
Journal:  Surgery       Date:  2010-05-14       Impact factor: 3.982

5.  Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy.

Authors:  Andrew L Raines; Rene Olivares-Navarrete; Marco Wieland; David L Cochran; Zvi Schwartz; Barbara D Boyan
Journal:  Biomaterials       Date:  2010-03-30       Impact factor: 12.479

Review 6.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

7.  EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.

Authors:  Shek Man Chim; An Qin; Jennifer Tickner; Nathan Pavlos; Tamara Davey; Hao Wang; Yajun Guo; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

8.  Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds.

Authors:  Noah R Johnson; Yadong Wang
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

9.  CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling.

Authors:  Houjuan Zuo; Zhengxiang Liu; Xiaochun Liu; Jun Yang; Tao Liu; Sha Wen; Xin A Zhang; Katherine Cianflone; Daowen Wang
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

10.  Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.

Authors:  Mark Katakowski; Feng Jiang; XuGuang Zheng; Jorge A Gutierrez; Alexandra Szalad; Michael Chopp
Journal:  Cancer Sci       Date:  2009-05-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.